Northern Trust Corp Alvotech Transaction History
Northern Trust Corp
- $761 Billion
- Q3 2025
A detailed history of Northern Trust Corp transactions in Alvotech stock. As of the latest transaction made, Northern Trust Corp holds 95,890 shares of ALVO stock, worth $526,436. This represents 0.0% of its overall portfolio holdings.
Number of Shares
95,890
Previous 106,116
9.64%
Holding current value
$526,436
Previous $967,000
18.82%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ALVO
# of Institutions
66Shares Held
15MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA4.35MShares$23.9 Million0.0% of portfolio
-
Bracebridge Capital, LLC2.71MShares$14.9 Million12.58% of portfolio
-
Howard Marks Oaktree Capital Management LP | Los Angeles, Ca1.56MShares$8.58 Million0.33% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.45MShares$7.98 Million0.0% of portfolio
-
Littlejohn & CO LLC1.32MShares$7.24 Million12.0% of portfolio
About Alvotech
- Ticker ALVO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 248,650,000
- Market Cap $1.37B
- Description
- Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory condi...